Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride

Results in Pharma Sciences

Volumn 6, Issue , 2016, Pages 1-6

  Makwana, S B ^a   Patel, V A ^a   Parmar, S J ^a  

^a SARDAR PATEL UNIVERSITY   (India)

Author keywords

In situ gel; Ophthalmic delivery; pH; Sol gel transition

Indexed keywords

CALCIUM ALGINATE; CIPROFLOXACIN; DIVALENT CATION; METHYLCELLULOSE;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; CORNEA ULCER; DILUTION; DRUG FORMULATION; DRUG INSTILLATION; DRUG RETENTION; GEL; IN VITRO STUDY; PH; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; VISCOSITY;

EID: 84957803698     PISSN: None     EISSN: 22112863     Source Type: Journal    
DOI: 10.1016/j.rinphs.2015.06.001     Document Type: Article

References (22)

1. Gratieri T., Gelfuso G.M., de Freitas O.D., Rocha E.M., Lopez R.F. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming Gel. Eur. J. Pharm. Biopharm. 2011, 79(2):320-327. http://www.ncbi.nlm.nih.gov/pubmed/21641994, 10.1016/j.ejpb.2011.05.006.
2. Thimmasetty M.K., Mandal S., Prabhushankar G.L., Geetha M.S. Formulation and evaluation of an in situ gel of amoxicillin trihydrate. Int. J. Pharm. Investig. 2012, 2(2):78-82.
3. Vijaya C., Goud K.S. Ion-activated in situ gelling ophthalmic delivery systems of azithromycin. Indian J. Pharm. Sci. 2011, 73(6):615-620. http://www.ncbi.nlm.nih.gov/pubmed/23112394, 10.4103/0250-474X.100234.
4. Majithiya R.J., Ghosh P.K., Umrethia M.L., Murthy R.S. Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan. AAPS PharmSciTech 2006, 7(3):67. http://www.ncbi.nlm.nih.gov/pubmed/17025248, 10.1208/pt070367.
5. The Indian Pharmacopoeia, The Indian Pharmacopoeia Commission: Ghaziabad, India, Published by Ministry of Health and Public Welfare, Government of India, New Delhi vol. 2, 2010, p. 1032.
6. Nagesh C., Patil M., Chandrashekhara S., Sutar R. A novel in situ gel for sustained ophthalmic delivery of ciprofloxacin hydrochloride and dexamethasone design and characterization. Pharm. Lett. 2012, 4(3):821-827.
7. Liu Z., Li J., Nie S., Liu H., Ding P., Pan W. Study of an alginate/Hpmc-Based in situ gelling ophthalmic delivery system for gatifloxacin. Int. J. Pharm. 2006, 315(1-2):12-17. http://www.ncbi.nlm.nih.gov/pubmed/16616442, 10.1016/j.ijpharm.2006.01.029.
8. Mohanambal E., Arun K., Sathali A. Formulation and evaluation of pH-triggered in situ gelling system of levofloxacin. Ind. J. Pharm. Educ. Res. 2011, 45(1):58-64.
9. Chu K., Chen L., Xu W., et al. Preparation of A paeonol-containing temperature-sensitive in situ gel and its preliminary efficacy on allergic rhinitis. Int. J. Mol. Sci. 2013, 14(3):6499-6515. http://www.ncbi.nlm.nih.gov/pubmed/23525047, 10.3390/ijms14036499.
10. Gowda D.V., Tanuja D., Khan M.S., Desai J., Shivakumar H.G. Formulation and evaluation of in-situ gel of diltiazem hydrochloride for nasal delivery. Pharm. Lett. 2011, 3(1):371-381.
11. Geethalakshmi A., Karki R., Jha S.K., Venkatesh D.P., Nikunj B. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system. Curr. Drug Deliv. 2012, 9(2):197-204. http://www.ncbi.nlm.nih.gov/pubmed/22283647, 10.2174/156720112800234530.
12. Wee S., Gombotz W.R. Protein release from alginate matrices. Adv. Drug Deliv. Rev. 1998, 31(3):267-285. http://www.ncbi.nlm.nih.gov/pubmed/10837629, 10.1016/S0169-409X(97)00124-5.
13. Khairnar P.S., Walke P.S., Narkhede M.R., Nehete J.Y. Formulation and in-vitro evaluation of thermoreversible rizatriptan benzoate nasal gel. Int. J. Pharm. Pharm. Sci. 2011, 3(4):250-256.
14. Chelladurai S., Mishra M., Mishra B. Design and evaluation of bioadhesive in-situ nasal Gel of ketorolac tromethamine. Chem. Pharm. Bull. 2008, 56(11):1596-1599. http://www.ncbi.nlm.nih.gov/pubmed/18981612, 10.1248/cpb.56.1596.
15. (accessed 10.2.14). http://www.Pharmatutor.org.
16. Nisha G.S., Maithil P., Charyulu R.N. Formulation and development of nasal in situ gels of triptans for antimigraine activity. Int. J. Res. Pharm. Biomed. Sci. 2012, 3(2):861-868.
17. Dholakia M., Thakkar V., Patel N., Gandhi T. Development and characterisation of thermo reversible mucoadhesive moxifloxacin hydrochloride in situ ophthalmic gel. J. Pharm. Bioallied Sci. 2012, 4:S42-S45. http://www.ncbi.nlm.nih.gov/pubmed/23066202, 10.4103/0975-7406.94138.
18. Gupta S., Vyas S.P. Carbopol/chitosan based Ph triggered in situ gelling system for ocular delivery of timolol maleate. Sci. Pharm. 2010, 78(4):959-976. http://www.ncbi.nlm.nih.gov/pubmed/21179328, 10.3797/scipharm.1001-06.
19. Patel M., Thakkar H., Kasture P.V. Preparation and evaluation of Thermoreversible formulations of flunarizine hydrochloride for nasal delivery. Int. J. Pharm. Pharm. Sci. 2010, 2(4):116-120.
20. Liu Y., Liu J., Zhang X., Zhang R., Huang Y., Wu C. In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery. Aaps PharmSciTech 2010, 11(2):610-620. http://www.ncbi.nlm.nih.gov/pubmed/20354916, 10.1208/s12249-010-9413-0.
21. Liu Z., Li J., Nie S., Liu H., Ding P., Pan W. Study of an alginate/HPMC-Based in situ gelling ophthalmic delivery system for gatifloxacin. Int. J. Pharm. 2006, 315(1-2):12-17. http://www.ncbi.nlm.nih.gov/pubmed/16616442, 10.1016/j.ijpharm.2006.01.029.
22. Mundada A.S., Shrikhande B.K. Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert. Curr. Eye Res. 2008, 33(5):469-475. http://www.ncbi.nlm.nih.gov/pubmed/18568884, 10.1080/02713680802023104.